Cargando…
Are type I dural arteriovenous fistulas safe? Single-centre experience of endovascular treatment of dural arteriovenous fistulas
INTRODUCTION: There are mixed reports on the incidence of intracranial haemorrhage in patients with dural arteriovenous fistulas. We assessed new proposed risk factors (i.a. number of outflows and outflow diameter) of intracerebral haemorrhage due to intracranial dural arteriovenous fistula and pres...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717945/ https://www.ncbi.nlm.nih.gov/pubmed/31481988 http://dx.doi.org/10.5114/pjr.2019.84602 |
_version_ | 1783447647058657280 |
---|---|
author | Brzozowski, Krzysztof Narloch, Jerzy Piasecki, Piotr Zięcina, Piotr Koziarski, Andrzej |
author_facet | Brzozowski, Krzysztof Narloch, Jerzy Piasecki, Piotr Zięcina, Piotr Koziarski, Andrzej |
author_sort | Brzozowski, Krzysztof |
collection | PubMed |
description | INTRODUCTION: There are mixed reports on the incidence of intracranial haemorrhage in patients with dural arteriovenous fistulas. We assessed new proposed risk factors (i.a. number of outflows and outflow diameter) of intracerebral haemorrhage due to intracranial dural arteriovenous fistula and presented our personal experience in endovascular treatment of dural arteriovenous fistulas. MATERIAL AND METHODS: The patient database from January 2006 and December 2016 was reviewed, and 25 patients with 28 dural arteriovenous fistulas were identified. RESULTS: 50% of patients presented with intracerebral haemorrhage. Multiple dural fistulas occurred in 12% of patients. Spearman’s rank correlation coefficient revealed that there was a strong association between Cognard classification type and time needed to treat (r = 0.59, p < 0.05), as well as the volume of contrast used (r = 0.77, p < 0.05). Infratentorial (r = 0.53, p < 0.05) and right-sided (r = 0.66, p < 0.05) localisation were more challenging to treat. Bleeding was associated with poorer clinical outcome (r = 0.48, p < 0.05). No significant differences were found between the non-haemorrhagic group and the haemorrhagic group regarding the number of outflows (p = 0.459) and largest outflow diameter (p = 0.298). Clinical evaluation at follow-up was as follows: 56% of patients were asymptomatic, 24% had non-significant disability, maintaining independency, 16% had moderate disability, and 8% died – one in the course of intracerebral haemorrhage and one due to other sustained injuries. There were no reported embolisation-related complications. CONCLUSIONS: To conclude, regardless of presentation, both symptomatic and asymptomatic dural arteriovenous fistulas deserve clinical attention, structured evaluation, and follow-up. Type I fistulas were associated with haemorrhage in 1/3 of all cases. Overall our results indicate that the risk of haemorrhage and dire consequences is multifactorial. |
format | Online Article Text |
id | pubmed-6717945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-67179452019-09-03 Are type I dural arteriovenous fistulas safe? Single-centre experience of endovascular treatment of dural arteriovenous fistulas Brzozowski, Krzysztof Narloch, Jerzy Piasecki, Piotr Zięcina, Piotr Koziarski, Andrzej Pol J Radiol Original Paper INTRODUCTION: There are mixed reports on the incidence of intracranial haemorrhage in patients with dural arteriovenous fistulas. We assessed new proposed risk factors (i.a. number of outflows and outflow diameter) of intracerebral haemorrhage due to intracranial dural arteriovenous fistula and presented our personal experience in endovascular treatment of dural arteriovenous fistulas. MATERIAL AND METHODS: The patient database from January 2006 and December 2016 was reviewed, and 25 patients with 28 dural arteriovenous fistulas were identified. RESULTS: 50% of patients presented with intracerebral haemorrhage. Multiple dural fistulas occurred in 12% of patients. Spearman’s rank correlation coefficient revealed that there was a strong association between Cognard classification type and time needed to treat (r = 0.59, p < 0.05), as well as the volume of contrast used (r = 0.77, p < 0.05). Infratentorial (r = 0.53, p < 0.05) and right-sided (r = 0.66, p < 0.05) localisation were more challenging to treat. Bleeding was associated with poorer clinical outcome (r = 0.48, p < 0.05). No significant differences were found between the non-haemorrhagic group and the haemorrhagic group regarding the number of outflows (p = 0.459) and largest outflow diameter (p = 0.298). Clinical evaluation at follow-up was as follows: 56% of patients were asymptomatic, 24% had non-significant disability, maintaining independency, 16% had moderate disability, and 8% died – one in the course of intracerebral haemorrhage and one due to other sustained injuries. There were no reported embolisation-related complications. CONCLUSIONS: To conclude, regardless of presentation, both symptomatic and asymptomatic dural arteriovenous fistulas deserve clinical attention, structured evaluation, and follow-up. Type I fistulas were associated with haemorrhage in 1/3 of all cases. Overall our results indicate that the risk of haemorrhage and dire consequences is multifactorial. Termedia Publishing House 2019-04-05 /pmc/articles/PMC6717945/ /pubmed/31481988 http://dx.doi.org/10.5114/pjr.2019.84602 Text en Copyright © Polish Medical Society of Radiology 2019 https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0). License allowing third parties to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially. |
spellingShingle | Original Paper Brzozowski, Krzysztof Narloch, Jerzy Piasecki, Piotr Zięcina, Piotr Koziarski, Andrzej Are type I dural arteriovenous fistulas safe? Single-centre experience of endovascular treatment of dural arteriovenous fistulas |
title | Are type I dural arteriovenous fistulas safe? Single-centre experience of endovascular treatment of dural arteriovenous fistulas |
title_full | Are type I dural arteriovenous fistulas safe? Single-centre experience of endovascular treatment of dural arteriovenous fistulas |
title_fullStr | Are type I dural arteriovenous fistulas safe? Single-centre experience of endovascular treatment of dural arteriovenous fistulas |
title_full_unstemmed | Are type I dural arteriovenous fistulas safe? Single-centre experience of endovascular treatment of dural arteriovenous fistulas |
title_short | Are type I dural arteriovenous fistulas safe? Single-centre experience of endovascular treatment of dural arteriovenous fistulas |
title_sort | are type i dural arteriovenous fistulas safe? single-centre experience of endovascular treatment of dural arteriovenous fistulas |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717945/ https://www.ncbi.nlm.nih.gov/pubmed/31481988 http://dx.doi.org/10.5114/pjr.2019.84602 |
work_keys_str_mv | AT brzozowskikrzysztof aretypeiduralarteriovenousfistulassafesinglecentreexperienceofendovasculartreatmentofduralarteriovenousfistulas AT narlochjerzy aretypeiduralarteriovenousfistulassafesinglecentreexperienceofendovasculartreatmentofduralarteriovenousfistulas AT piaseckipiotr aretypeiduralarteriovenousfistulassafesinglecentreexperienceofendovasculartreatmentofduralarteriovenousfistulas AT ziecinapiotr aretypeiduralarteriovenousfistulassafesinglecentreexperienceofendovasculartreatmentofduralarteriovenousfistulas AT koziarskiandrzej aretypeiduralarteriovenousfistulassafesinglecentreexperienceofendovasculartreatmentofduralarteriovenousfistulas |